|Articles|April 2, 2009

Improving Post-PCI Outcomes: Therapeutic Considerations for Managed Care [CME/CPE]
Volume 15
Issue 2 Suppl

Improving Post-PCI Outcomes: Therapeutic Considerations for Managed Care

Download PDF: Improving Post-PCI Outcomes: Therapeutic Considerations for Managed Care

Articles in this issue

over 17 years ago

Article

Antiplatelet Therapy for Improving Post-PCI Outcomes: Interpreting Current Treatment Guidelines for Optimal Management of the Post-ACS Patient

over 17 years ago

Article

Percutaneous Coronary Intervention: Assessing Coronary Vascular Risk Associated With Bare-Metal and Drug-Eluting Stents

over 17 years ago

Article

Participating Faculty

over 17 years ago

Article

Introduction

over 17 years ago

Article

Acute Coronary Syndromes: Morbidity, Mortality, and Pharmacoeconomic Burden

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Improving Post-PCI Outcomes: Therapeutic Considerations for Managed Care

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis

Diagnosing Alzheimer's Disease Agitation: Triggers, Care Specialties, and the Role of Primary Care

Defining Alzheimer's Disease Agitation: Diagnostic Criteria, Symptoms, and Disease Course

Small Workflow Changes Close Big Gaps in CKM Screening

Pirtobrutinib Plus Venetoclax-Rituximab Cuts CLL Progression 45%